ID

20225

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Keywords

  1. 2/15/17 2/15/17 -
Uploaded on

February 15, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Treatment Visit 2 Month 1 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Treatment Visit 2 Month 1 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Concomitant Medication
Description

Concomitant Medication

Alias
UMLS CUI-1
C2347852
1. Since the last visit, were any of the non-study medications listed below taken?
Description

Concomitant medication

Data type

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
If yes, please indicate which of the following were taken:
Description

If yes, please indicate which

Data type

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1524063
ACE Inhibitors
Description

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
2. Since the last visit, were any ACE inhibitors taken?
Description

ACE Inhibitors currently taken

Data type

boolean

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
If yes, please indicate which, and total daily dose:
Description

If yes

Data type

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
UMLS CUI [2]
C2348070
Restricted Concomitant Medication
Description

Restricted Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0443288
3. Have any restricted medications in the categories defined on the opposite page been taken?
Description

Restricted medication taken

Data type

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
UMLS CUI [1,4]
C0443288
If yes, please indicate which category
Description

if yes

Data type

integer

Alias
UMLS CUI [1,1]
C0683312
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0443288
Tobacco Use Status
Description

Tobacco Use Status

Alias
UMLS CUI-1
C0543414
UMLS CUI-2
C0449438
4. Has the patient smoked in the last week?
Description

Smoked last week

Data type

boolean

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C2987125
If the patient smoked cigarettes number of cigarettes per day
Description

Number of cigarettes per day

Data type

float

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C3694146

Similar models

Treatment Visit 2 Month 1 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant medication
Item
1. Since the last visit, were any of the non-study medications listed below taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Item
If yes, please indicate which of the following were taken:
integer
C2347852 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Code List
If yes, please indicate which of the following were taken:
CL Item
Parental anticoagulants (Short term use)  (1)
CL Item
Oral anticoagulants (Short term use) (2)
CL Item
Nitrates (oral or topical) (3)
CL Item
Estrogen replacement without progesterone (4)
CL Item
Estrogen replacement with progesterone (5)
CL Item
Digitalis (6)
CL Item
Statins (7)
CL Item
Fibrates (8)
CL Item
Dilitazem/Verapamil (9)
CL Item
Other calcium channel blockers (10)
CL Item
Alpha-blocker (11)
CL Item
Direct vasodilators (12)
CL Item
Peripheral sympatholytic (13)
CL Item
Central sympatholytic (14)
CL Item
Alpha-beta blocker (15)
CL Item
Beta-blocker (16)
CL Item
Loop-active diuretics (17)
CL Item
Diuretics of thiazide type (18)
CL Item
Potassium-sparing diuretics (19)
CL Item
Insulin (20)
CL Item
Oral hypoglycemic agents (21)
CL Item
Specific Cox II inhibitors (22)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
2. Since the last visit, were any ACE inhibitors taken?
boolean
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes
Item
If yes, please indicate which, and total daily dose:
text
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C2348070 (UMLS CUI [2])
Item Group
Restricted Concomitant Medication
C2347852 (UMLS CUI-1)
C0443288 (UMLS CUI-2)
Restricted medication taken
Item
3. Have any restricted medications in the categories defined on the opposite page been taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
C0443288 (UMLS CUI [1,4])
Item
If yes, please indicate which category
integer
C0683312 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,3])
Code List
If yes, please indicate which category
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
Item Group
Tobacco Use Status
C0543414 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Smoked last week
Item
4. Has the patient smoked in the last week?
boolean
C0543414 (UMLS CUI [1,1])
C2987125 (UMLS CUI [1,2])
Number of cigarettes per day
Item
If the patient smoked cigarettes number of cigarettes per day
float
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial